PubMed · 12888290
Cycling without CDK2?
Abstract
Cyclin-dependent kinase 2 (CDK2) regulates diverse aspects of the mammalian cell cycle. Most cancer cells contain mutations in the pathways that control CDK2, and CDK2 activity has received much attention as a target for cancer therapy. However, a recent report demonstrating that some cancer cells can proliferate without CDK2 activity questions the essential role of CDK2 in cell-cycle control, as well as its suitability as a therapeutic target.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jonathan E Grim, Bruce E Clurman. 2003. Cycling without CDK2?. https://doi.org/10.1016/s0962-8924(03)00148-x
Cite the original work for its findings. Save a collection to share your selection of sources.